These findings appear to conflict with our observation of decreased TNFRSF4 expression in cisplatin-resistant lymph node metastases in neuroblastoma; however, many of these studies assessed TNFRSF4 expression in lymphocytes within tumour-positive lymph nodes rather than in tumour cells themselves, as we did in our study. This evidence concerns the gene TNFRSF4 and neoplasm.